These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 853306)

  • 1. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.
    Gentleman S; Parenti M; Neff NH; Pert CB
    Cell Mol Neurobiol; 1983 Mar; 3(1):17-26. PubMed ID: 6309392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 2-chloro-11-(4-methyl-l-piperazinyl) dibenz(b,f)(1,4)oxazepine (loxapine) and its derivatives on the dopamine-sensitive adenylate cyclase of rat striatal homogenates.
    Coupet J; Szucs VA; Greenblatt EN
    Brain Res; 1976 Oct; 116(1):177-80. PubMed ID: 974768
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
    Roufogalis BD; Thornton M; Wade DN
    J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P; Verwimp M; Janssen PF; Leysen J
    Life Sci; 1976 Feb; 18(4):433-9. PubMed ID: 130527
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary.
    Schmidt MJ; Hill LE
    Life Sci; 1977 Mar; 20(5):789-97. PubMed ID: 15714761
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
    Fleminger S
    Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum.
    Pagnini G; Camanni F; Crispino A; Portaleone P
    J Pharm Pharmacol; 1978 Feb; 30(2):92-5. PubMed ID: 24111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence does not alter activation or inhibition of striatal adenylate cyclase.
    Rabin RA
    Neurobiol Aging; 1986; 7(1):49-51. PubMed ID: 3951659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oxiferriscorbone on striatal adenylate cyclase of the rat.
    Moser A; Schuster O
    Neuropharmacology; 1990 Aug; 29(8):731-4. PubMed ID: 2274108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
    J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).
    Miller RJ; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):213-6. PubMed ID: 4369214
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of octopamine on dopamine D-1 receptor in striatal homogenates of the rat.
    Cheng JT; Shen CL; Jou TC
    Neurosci Res; 1990 Dec; 9(3):202-7. PubMed ID: 1963678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine.
    Woodruff GN; Watling KJ; Andrews CD; Poat JA; McDermed JD
    J Pharm Pharmacol; 1977 Jul; 29(7):422-7. PubMed ID: 19581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
    Miller RJ; Horn AS; Iversen LL
    J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.